Vasopressin role in hypertrophic obstructive cardiomyopathy post-cardiac surgery: A case report

血管加压素在心脏手术后肥厚型梗阻性心肌病中的作用:病例报告

阅读:4

Abstract

BACKGROUND: Managing left ventricular outflow tract obstruction (LVOTO) and systolic anterior motion (SAM) of the mitral valve can be challenging, especially in the context of circulatory shock and pulmonary edema post cardiac surgery. CASE SUMMARY: We describe a case of an 80-year-old female patient with a history of severe aortic stenosis and hypertrophic obstructive cardiomyopathy that underwent aortic valve replacement and myectomy. The patient presented with acute pulmonary edema and low blood pressure due to LVOTO and SAM post cardiac surgery in the intensive care unit. She was paced with an epicardial dual-chamber pacing system due to complete atrioventricular block and treated initially with norepinephrine, furosemide, and esmolol infusion and continuous positive pressure ventilation. The patient remained hypoxemic and kept deteriorating hemodynamically despite titrating up norepinephrine. The addition of vasopressin infusion and tapering of norepinephrine finally stabilized the patient with significant reduction of LVOTO, confirmed by transthoracic echocardiography assessment, improved oxygenation and increased urine output. CONCLUSION: Vasopressin seems to be the preferred vasopressor for managing LVOTO and SAM post-cardiac surgery, because of its absence of inotropic effects. Echocardiography is crucial for early diagnosis and therapeutic management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。